AAP Guidance: Resolving Disputes Over Nonbeneficial Pediatric Treatment

March 23, 2026 Ananya Mittal - World Editor

Navigating disagreements around a child’s medical care is rarely simple. New guidance released today, March 23, 2026, by the American Academy of Pediatrics (AAP) addresses a particularly complex scenario: parental requests for treatments that clinicians believe offer no medical benefit. The clinical report and accompanying technical report, published in Pediatrics, aim to provide a framework for resolving these disputes, prioritizing the well-being of the child while respecting parental rights and values.

Understanding “Nonbeneficial” Treatment

The core of this guidance revolves around defining what constitutes a “nonbeneficial” treatment. This isn’t simply a matter of disagreement over the best course of action, but rather a situation where a proposed treatment is unlikely to provide any therapeutic effect, and may even cause harm. This can range from interventions with no scientific basis to those that have been repeatedly shown to be ineffective. It’s important to note that perceptions of benefit can be deeply influenced by cultural beliefs, personal experiences, and differing interpretations of medical evidence.

The AAP acknowledges that parents often seek treatments driven by hope, even in the face of limited evidence. The report doesn’t aim to invalidate these feelings, but to offer a structured approach to conversations and decision-making. It emphasizes the importance of understanding the reasons behind a parental request, rather than immediately dismissing it.

The Ethical Landscape: Informed Consent and Parental Permission

The AAP’s stance is rooted in established principles of pediatric bioethics. As outlined in a 1995 statement on informed consent, parental permission, and patient assent , physicians generally have an ethical and legal obligation to obtain parental permission for medical interventions. However, this permission isn’t absolute. When a proposed treatment is deemed nonbeneficial, the physician’s responsibility shifts towards protecting the child from potential harm. Here’s where the potential for conflict arises.

The concept of “assent” – a child’s agreement to treatment, taking into account their age and maturity – also plays a role. While parents hold the legal authority to craft medical decisions for their children, involving the child in the process, when appropriate, is considered good practice.

A Framework for Resolution

The new AAP guidance doesn’t offer a rigid set of rules, but rather a series of steps to facilitate constructive dialogue. These include:

  • Open Communication: Clinicians are encouraged to engage in empathetic and respectful conversations with parents, actively listening to their concerns and understanding their motivations.
  • Evidence-Based Explanation: Clearly explaining the scientific evidence (or lack thereof) supporting a proposed treatment is crucial. This should be done in a way that is accessible and understandable to the parents, avoiding medical jargon.
  • Shared Decision-Making: Exploring alternative approaches that align with both the parents’ values and the child’s best interests.
  • Ethics Consultation: In cases where disagreements persist, involving an ethics committee or consultant can provide an objective perspective and help navigate the complex ethical considerations.

The report also acknowledges that, in rare and extreme cases, legal intervention may be necessary to protect a child from harmful treatment. However, this is presented as a last resort, to be pursued only after all other avenues have been exhausted.

Navigating Disputes: A Complex Process

The AAP report highlights the fact that these situations are rarely straightforward. Factors such as cultural beliefs, religious convictions, and differing levels of trust in the medical system can all contribute to the complexity. The guidance emphasizes the importance of cultural humility – recognizing and respecting the diverse values and perspectives of families.

It’s also important to acknowledge the potential for implicit bias to influence clinical decision-making. Clinicians should be aware of their own assumptions and biases, and strive to provide equitable care to all patients, regardless of their background or beliefs.

What Happens When Agreement Can’t Be Reached?

The AAP guidance doesn’t shy away from the tough question of what happens when parents and clinicians remain at odds. While the goal is always to reach a mutually acceptable solution, We find situations where this isn’t possible. In these cases, the report suggests that clinicians should prioritize the child’s best interests, even if it means disagreeing with the parents.

This can involve seeking legal counsel or, as a last resort, pursuing a court order to override parental wishes. However, the AAP emphasizes that such actions should be taken only in exceptional circumstances, and with careful consideration of the potential consequences for the family. The report also notes that guidelines on these issues can evolve; the AAP’s clinical reports are typically reviewed and updated every five years, or sooner if necessary .

Ongoing Challenges and Future Directions

The release of this guidance comes at a time when parental requests for nonbeneficial treatments are becoming increasingly common. This trend may be driven by the proliferation of misinformation online, as well as a growing distrust of traditional medical institutions. Addressing these underlying issues will require a multi-faceted approach, including improved health literacy, increased transparency in medical research, and a renewed focus on building trust between clinicians and patients.

The AAP’s report represents an important step towards providing a framework for navigating these challenging situations. However, it’s not a definitive solution. Ongoing dialogue, education, and a commitment to shared decision-making will be essential to ensuring that all children receive the best possible care. Further research is needed to understand the factors that contribute to parental requests for nonbeneficial treatments, and to develop effective strategies for addressing them. The Drugs.com report on the AAP guidelines notes the report was issued alongside a technical report offering further detail .